Remember when “Make in India” was just a slogan on hoardings? MTAR seems to be taking it as a literal manufacturing marathon. Q1 FY26 saw revenue jump 22% YoY despite juggling clean energy, aerospace, nuclear, oil & gas, and the occasional ISRO hardware. EBITDA grew 71% YoY, proving that if you bolt enough high-precision metal together, margins do follow.
Why it matters? Because MTAR isn’t just chasing orders — it’s lining up billion-rupee nuclear contracts, multi-year oil & gas deals, and a 25% wallet-share bump from Bloom Energy.
Stick around—things get spicier two scrolls down.
AT A GLANCE
• Revenue up 22% YoY – engineers worked overtime, not Excel.
• EBITDA margin at 18.1% – precision parts, precision profits.
• PAT up 144% YoY – nuclear reactors and hot boxes pay well.
• Order book visibility: ₹1,000 cr nuclear pipeline – the real heavy metal.
MANAGEMENT’S KEY COMMENTARY
Srinivas Reddy (MD): “We anticipate sequential improvements, especially in H2.”
– Translation: Q4 will be a blockbuster if tenders land.
On Clean Energy: “Bloom gave us the highest forecast ever post-tariffs.”
– Translation: trade wars are someone else’s problem, not ours.
On Nuclear: “₹1,000 crore orders expected in 3–6 months.”
– Translation: reactor core parts are the new blue-chip.
On Aerospace: “Targeting 80% revenue growth in FY26.”
– Translation: Europe’s defence supply chain crisis = our sales pipeline.
On Oil & Gas: “Long-term deal with Weatherford, new SEZ facility.”
– Translation: drilling down into
